Precision BioSciences Q1 EPS $1.70 Beats $(1.91) Estimate, Sales $17.58M Beat $6.02M Estimate

Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $(1.91) by 189.01 percent. This is a 124.64 percent increase over losses of $(6.90) per share from the same period last year. The company reported quarterly sales of $17.58 million which beat the analyst consensus estimate of $6.02 million by 192.09 percent. This is a 100.27 percent increase over sales of $8.78 million the same period last year.